Page last updated: 2024-09-03

2-pyrrolino-dox and Lymphoma, Non-Hodgkin

2-pyrrolino-dox has been researched along with Lymphoma, Non-Hodgkin in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Engel, JB; Halmos, G; Hammann, B; Keller, G; Nagy, A; Schally, AV1

Other Studies

1 other study(ies) available for 2-pyrrolino-dox and Lymphoma, Non-Hodgkin

ArticleYear
Growth inhibition of experimental non-Hodgkin's lymphomas with the targeted cytotoxic somatostatin analogue AN-238.
    International journal of cancer, 2005, May-01, Volume: 114, Issue:5

    Topics: Animals; Antineoplastic Agents; Body Weight; Doxorubicin; Humans; Kinetics; Leukocytes; Lymphoma, Non-Hodgkin; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Peptides; Pyrroles; Receptors, Somatostatin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Somatostatin; Time Factors

2005